USD 175.7 million
Mitomycin Market Size, Share, and Growth Analysis
Mitomycin Market By Cancer Type (Gastrointestinal Cancers (Stomach, Colon), Bladder Cancer), By Route of Administration (Intravenous (IV) Administration, Intravesical Administration), By Distribution Channel, By End-User, By Region - Industry Forecast 2025-2032
Report ID:
SQMIG15E2442 |
Region:
Global |
Published Date: December, 2024
Pages:
157
|Tables:
63
|Figures:
75
Format -
Mitomycin Market Insights
Global Mitomycin Market size was valued at USD 175.7 million in 2023 and is poised to grow from USD 191.68 million in 2024 to USD 384.76 million by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).
Mitomycin is a cancer treatment medicine that prevents or significantly delays the division of active cells by influencing their metabolism in various ways. The therapeutic application of medicinal products for cancer treatment is since cancer cells differ from normal cells in the body in that their rate of cell division is increased due to a lack of control over their growth.
It has been a blockbuster drug for cancer treatment since its FDA approval in 2019. It accelerates the chemotherapy process and, eventually, the entire treatment by inhibiting DNA synthesis. The market has experienced tremendous growth in recent years. The significant increase in cancer cases worldwide has greatly increased its demand.
US Mitomycin Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Cancer Treatment
Fastest Growth
Cancer Treatment
Growth Rate
9.1% CAGR
Global Mitomycin Market ($ Bn)
Country Share for Asia Pacific Region (%)
To get more reports on the above market click here to Buy The Report
Mitomycin Market Segments Analysis
Global Mitomycin Market is segmented by cancer type, route of administration, distribution channel, end-user and region. Based on cancer type, the market is segmented into gastrointestinal cancers (stomach, colon), bladder cancer, lung cancer, breast cancer, head and neck cancers and other cancers. Based on route of administration, the market is segmented into intravenous (IV) administration, intravesical administration and other routes. Based on distribution channel, the market is segmented into hospital pharmacies, specialty pharmacies, retail pharmacies and online pharmacies. Based on end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, cancer research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Mitomycin Market Analysis by Application
In terms of application, Cancer treatment dominated the global market in 2021 and is projected to show a similar trend over the forecast period. Mitomycin has a broad clinical antitumor spectrum, with effectiveness in a variety of tumour types including gastric cancer, pancreatic cancer, breast cancer, non-small cell lung cancer, cervical cancer, prostate cancer, and bladder cancer.
Global Mitomycin Market By Application
To get detailed analysis on other segments, Request For Free Sample Report
Mitomycin Market Regional Insights
Asia Pacific is quickly emerging as a lucrative market for mitomycin, with Japan emerging as the world's leading supplier of this drug. Its production is also increasing significantly in India, which benefits the Asia Pacific market. Leading manufacturers are actively expanding their operations in this region, which is expected to boost its prominence in the global market.
Global Mitomycin Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Mitomycin Market Dynamics
Mitomycin Market Driver
Increasing Ophthalmology Utilization Creates Opportunities for Drugmakers
- The growing global frequency of cancer has significantly boosted the need for mitomycin. Its low cost has given it an advantage over alternative therapy options. Its popularity will continue to grow, and it will continue to generate huge demand in the foreseeable future. It is widely used in the treatment of melanoma, colorectal cancer, prostate cancer, lung cancer, blood cancer, breast cancer, and a variety of ophthalmic conditions.
Mitomycin Market Restraint
Increasing cost
- Without insurance, its typical cost may be about $697.84 or more. When using a SingleCare Mitomycin discount card, customers may purchase Mitomycin for just $104.62 every 1, 20MG Solution Reconstituted. These quick discounts may be redeemed at a variety of well-known pharmacies, including CVS Pharmacy, Walmart Pharmacy, Walgreens, and Kroger.
Request Free Customization of this report to help us to meet your business objectives.
Mitomycin Market Competitive Landscape
The worldwide mitomycin market has a low level of competition. A few players wield considerable power, including Kyowa-kirin, Intas Pharmaceuticals, Speciality European Pharma, Teva Pharmaceuticals, Bristol-Myers Squibb, Rocket Pharmaceuticals, and Aspen. These firms are continually attempting to produce improved items in order to provide their customers with highly efficient medications. As an example: Rocket Pharma has announced the start of a stage 2 study for a medication intended to be used in gene therapy for the treatment of fanconi anaemia, a rare condition. This trial stage will largely assess this drug's resistance to mitomycin C, a DNA damaging chemo agent, over a one-year period.
Top Players in Mitomycin Market
- Kyowa Kirin Co., Ltd. (Japan)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Bristol-Myers Squibb Company (United States)
- Aspen Pharmacare Holdings Limited (South Africa)
- Zydus Lifesciences Limited (India)
- Cipla Limited (India)
- Jiangsu Hengrui Medicine Co., Ltd. (China)
- Pfizer Inc. (United States)
- Mylan N.V. (United States)
- Dr. Reddy's Laboratories Ltd. (India)
- Wockhardt Ltd. (India)
- Sun Pharmaceutical Industries Ltd. (India)
- Novartis International AG (Switzerland)
- Sanofi S.A. (France)
- Roche Holding AG (Switzerland)
- Merck & Co., Inc. (United States)
- Eli Lilly and Company (United States)
- Johnson & Johnson (United States)
- GlaxoSmithKline plc (United Kingdom)
- AstraZeneca plc (United Kingdom)
Mitomycin Market Recent Developments
- In Feb 2022, UroGen has begun a pivotal single-arm Phase 3 trial for UGN-102, an investigational non-surgical treatment for low-grade intermediate-risk non-muscle invasive bladder cancer. UroGen Pharma Ltd. has begun the Phase 3 ENVISION trial of UGN-102 (mitomycin) for intravesical solution in patients with low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC).
- In Jan 2022, Kyowa Kirin, located in Tokyo, applied for Japanese licensing of Mitomycin-C (mitomycin) as a topical ocular medication for use in glaucoma surgery.
Mitomycin Key Market Trends
- There are no Mitomycin patient assistance programs or manufacturer discounts available currently. Customers are encouraged to contact the maker of this drug to learn about any available savings offers, such as rebates, printable coupons, or free coupon codes.
- Mitomycin is used to treat a variety of cancers, including stomach cancer and pancreatic cancer. This medicine solely addresses cancer-related symptoms; it does not cure cancer. It acts by reducing or preventing cancer cell development and spread.
Mitomycin Market SkyQuest Analysis
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by robust Secondary Desk research.
According to our Market Analysis, Global Mitomycin Market is relatively consolidated, with a low level of competition. Companies are working on studies and products are in pipeline. These industry leaders are expanding their client base in a variety of ways, and many organizations are forming strategic and creative partnerships with other start-up businesses to increase market share and profitability.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 175.7 million |
| Market size value in 2032 | USD 384.76 million |
| Growth Rate | 9.1% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Mitomycin Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Mitomycin Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Mitomycin Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Mitomycin Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Mitomycin Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Mitomycin Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Mitomycin Market Report Snapshots
REQUEST FOR SAMPLE
Want to customize this report?
REQUEST FREE CUSTOMIZATION
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
